-The Hindu After a long and painful period of neglect, India promises to devote attention to the issue of preparing all children for primary schooling. The draft National Early Childhood Care and Education (ECCE) policy aims to end the "current laissez faire situation" that has led to the mushrooming of expensive crèches, play schools, nursery schools and so on that adhere to no particular standard. On the other hand, there is...

-The Times of India NEW DELHI: The Centre wants states reporting large number of road fatalities, injuries and accidents to focus on road safety to improve the country's performance as the United Nations has set a target of reducing deaths by 50% during this decade. Five states - Tamil Nadu, Uttar Pradesh, Andhra Pradesh, Madhya Pradesh and Rajasthan - accounted for over 50% of the country's road deaths in 2012. The number...

-The Hindu JENVAC is the first vaccine to be manufactured in the public-private partnership mode India on Friday launched its first indigenous vaccine to protect children from Japanese encephalitis. Until now, the country has been importing the vaccine from China. The Vero cell-derived purified inactivated JE vaccine-JENVAC, which received manufacturing and marketing approvals from the Drug Controller General of India, is the first vaccine to be manufactured in the public-private partnership mode between...

-The Times of India NEW DELHI: The Cabinet committee on economic affairs on Thursday approved Rs 8,632.77 crore for implementation of the National AIDS Control Programme Phase-IV by the Health ministry's department of AIDS control. The main objective of NACP IV is to reduce new infections by 50% (2007 baseline of NACP III) and provide comprehensive care and support to all persons living with HIV/AIDS and treatment services for all those who...

-Live Mint Apex court expresses concerns about drug trials being permitted on humans without comprehensive rules to regulate the approval process New Delhi: The apex court on Monday directed the Health ministry to justify its approval for 162 global clinical trials in India, increasing the uncertainty faced by the nation's $500 million clinical research industry. The Supreme Court expressed its concerns about drug trials being permitted on humans without comprehensive rules to...